Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Alla Stavnitser, BS
Advertisement
Articles by Alla Stavnitser, BS
Multiple sclerosis (MS) is of interest because it is one of the most costly neurological diseases and the introduction of the first oral treatments in 2010 amplified high treatment costs of MS even further.
Advertisement
Latest Updated Articles
- Impact of New Oral Therapies on Multiple Sclerosis Cost and Utilization Trends
Published: February 8th 2013 | Updated:
- Trends in Statin Treatment Costs and Potential Impact of Novel Therapies
Published: April 8th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
5
